» 2007 » January - Mesothelioma News

Offering hope, help, and support to mesothelioma patients and their families.

News Categories
- 9/11 Asbestos Risks (4)
- Asbestos & Mesothelioma Studies (95)
- Asbestos Abatement (74)
- Asbestos Bankruptcies (1)
- Asbestos in Products (14)
- Asbestos in Schools (24)
- Asbestos Legislation (58)
- Drug Companies (87)
  - ImClone Systems Incorporated (1)
  - Alfacell (27)
  - Bristol-Myers Squibb (1)
  - CuraGen (1)
  - Eli Lilly (19)
  - Fujirebio Diagnostics, Inc. (9)
  - Genentech (1)
  - Innovive Pharmaceuticals (3)
  - MolMed (1)
  - NeoPharm, Inc. (1)
  - Raptor Pharmaceuticals Corporation (1)
  - Rosetta Genomics (7)
  - Solbec Pharmaceuticals Ltd (1)
  - TopoTarget (1)
  - Zengen, Inc. (1)
- Full Archive (386)
- Libby, MT (15)
- Novel Treatments & Drugs (103)
  - Avastin (3)
  - Carboplatin (ParaplatinÂ®) (8)
  - Cisplatin (Platinol Â®) (12)
  - Coramsine (1)
  - Gemcitabine (1)
  - histone deacetylase inhibitors (1)
  - melanocortin receptors (MCR) subtypes MC1R and MC3R (1)
  - MESOMARK (8)
  - Mesothelioma Blood Test (12)
  - Onconase (ranpirnase) (23)
  - Pemetrexed (Alimta) (28)
  - Raltitrexed (TomudexÂ®) (2)
- Organizations (206)
  - Asbestos Disease Awareness Organization (ADAO) (74)
  - Cancer Monthly (9)
  - Centers for Disease Control (CDC) (4)
  - Environmental Protection Agency (EPA) (67)
  - Environmental Working Group (EWG) (6)
  - Mesothelioma Applied Research Foundation (MARF) (35)
  - NYU Medical Center (1)
- Polio Vaccine – Simian Virus 40 (SV40) (3)
- Trust Funds (10)
Meso News Archives:
- 2012
- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
- 1998
You are currently browsing the Mesothelioma News weblog archives for January, 2007.

Archive for January, 2007

Tuesday, January 30th, 2007 - Alfacell Corporation Granted U.S. Orphan Drug Designation for ONCONASE® for Treatment of Malignant Mesothelioma: First-in-Class RNAi Drug in Phase IIIB Confirmatory Trial for Unresectable

Thursday, January 25th, 2007 - Fujirebio Diagnostics Receives FDA Approval for the MESOMARK® Assay for the Management of Mesothelioma Patients

Wednesday, January 24th, 2007 - Asbestos Disease Awareness Organization (ADAO) Mourns the Passing of Montana Miner and Activist, Les Skramstad

Wednesday, January 3rd, 2007 - Asbestos Disease Awareness Organization (ADAO) Awards Leading Voices in Asbestos Awareness Top Honors

Main:

Home | Contact The Mesothelioma Center

Asbestos Diseases:

Asbestos:

About Asbestos | Asbestos in Materials | Products that contain Asbestos

Hope & Help:

Support | Patient Network | Support Groups | Doctors/Specialists

Info & Resources:

Common Questions | News | Web Resources | Site Map

Looking for mesothelioma lawyers? Experienced asbestos attorneys.

Please read our disclaimer. Goldberg, Persky & White, P.C.

Last Updated: January 13, 2012. 06:25:40 pm.

News Categories

Meso News Archives:

Archive for January, 2007